Developmental Regression and Epileptic Encephalopathy
A 4-year-old boy is brought for evaluation of developmental regression. He had been speaking in 2-3 word sentences and was toilet trained by age 3. Over the past 8 months, he has lost all spoken language and now has frequent episodes of staring, eyelid fluttering, and head nodding, especially upon awakening. His parents report that he becomes irritable and clumsy before these episodes. Examination shows mild hypotonia, ataxia, and drooling. An EEG obtained during sleep shows a generalized 1.5-2.5 Hz spike-wave pattern occupying >85% of the record. MRI brain is normal. He has no dysmorphic features. Family history is notable for a maternal uncle with febrile seizures and a cousin with autism. Genetic testing is pending.
1. What is the most likely diagnosis, and what is the pathophysiological basis for the EEG pattern?
Read the worked answer
The most likely diagnosis is epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS), also known as electrical status epilepticus during slow sleep (ESES). The EEG pattern of near-continuous generalized spike-wave discharges during non-REM sleep (>85% of slow-wave sleep) is the hallmark. This pattern is thought to result from an age-dependent, sleep-activated epileptic network that disrupts normal synaptic homeostasis and sleep-related memory consolidation, leading to cognitive and language regression. The clinical history of language loss, seizures, and ataxia supports this. The normal MRI and absence of dysmorphism make structural or metabolic causes less likely. The family history of seizures and autism suggests a possible genetic predisposition, but the diagnosis is electroclinical.
2. What treatment approach would you recommend, and what are the key considerations in monitoring?
Read the worked answer
Treatment aims to suppress the epileptic activity during sleep and improve cognition. Benzodiazepines (e.g., clobazam, clonazepam) are first-line, often given at bedtime to target the sleep-activated pattern. Valproate or levetiracetam may be used as adjuncts. Corticosteroids (e.g., prednisolone or ACTH) can be effective in refractory cases. Avoid carbamazepine and oxcarbazepine, which may exacerbate CSWS. Monitoring includes repeat overnight EEG to assess spike-wave index, serial neuropsychological testing, and tracking of language and behavior. The goal is to reduce the spike-wave index to <50% and to stabilize or improve cognition. Prognosis is variable; early aggressive treatment may improve outcome.